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Rather than being separated by discrete boundaries, the different phases of viral replication cycles partially
overlap one another. In this issue, Dale et al. (2011) describe a remarkable example of this phenomenon:
HIV-1 matures, and thus becomes infectious, but only after it has already started entering target cells.While, traditionally, many virologists have
focused on either the late or the early
phase of viral life cycles, several groups
have recently started to study the inter-
face between these two phases, specifi-
cally the events that occur when the virus
crosses barriers, as it is transmitted from
cell to cell. Increasingly sophisticated
imaging techniques allow scrutiny of
these events with high spatial resolution
and, more importantly, in real-time, ulti-
mately providing us with a dynamic view
of how a virus spreads within infected
organisms.
By classical definition, the early phase
of viral life cycles ends with the replication
of the viral genome. For HIV-1, as for other
members of the retrovirus family, this
occurs when the integrated provirus is
transcribed into RNA. However, the full-
length genomic RNA can also serve as
a template for the synthesis of the retro-
viral structural protein, Gag. Upon multi-
merization, the Gag polyproteins assem-
ble into a viral particle, whose release
and subsequent maturation marks the
end of the late phase of the viral life cycle.
Therefore, as illustrated in Figure 1
(bottom half of the cycle), the end of the
early phase (transcription of the viral
RNA genome) also constitutes the begin-
ning of the late phase of the viral replica-
tion cycle. It was not known, however,
that a similar overlap between the two
phases can takeplace also at the opposite
pole of the life cycle. Many structural and
functional studies have revealed that,
upon release and maturation, which leads
to the formation of their archetypical
cone-shaped core (Figure 1, top), viral
particles are metastable structures that
are prone to fall apart as soon as they
enter target cells. It was originally thought
though, that the viral entry process, which
leads to uncoating of the viral genome and
associated components, starts only aftermaturation of the viral particles. However,
the article by Dale et al. now reveals that
the early and late phases can also overlap
at this pole of the viral life cycle: it shows,
strikingly (and literally, as much of the
study consists of fluorescence micro-
graphs), that the late phase of the viral
replication cycle ends only when the early
phase is already in full swing.
Many viruses, including HIV-1 and other
retroviruses, are most efficiently trans-
mitted if they are released from infected
(producer) cells that transiently adhere to
uninfected (target) cells. Although known
for some time (discussed, e.g., in Mothes
et al. [2010]), it was only recently that the
term virological synapse (VS) was coined
to describe the adhesive structure that
allows passage of newly formed virions
between cells (Jolly et al., 2004). Two
years ago, Chen and colleagues provided
the first live-cell analysis of HIV-1 trans-
mission at the VS (Hu¨bner et al., 2009).
Already in that study, they presented
data suggesting that this virus can be
taken up into the endosomes of target
cells. That study, together with another
that focused onHIV-1 entry into T lympho-
cytes (Bosch, Grigorov et al., 2008), nicely
paralleled reports that showed that
viruses can enter (HeLa-derived) cells via
clathrin- and dynamin-dependent endo-
cytosis (Daecke et al., 2005; Miyauchi
et al., 2009; for a very recent review, see
Grove and Marsh, 2011).
With their current study, Chen and
colleagues (Dale et al., 2011) expand on
these observations and, importantly, now
link HIV-1 entry with the last step of viral
morphogenesis—i.e., with maturation.
While we know from biochemical and
morphological (electron microscopy)
analyses (several of which are cited in
Dale et al. [2011]) that HIV-1 matures
over the course of several hours after it is
released from infected cells, this studyCell Host & Microbe 10, Dnow demonstrates that an immature virus
can already start entering target cells
when it is transmitted through the VS.
Furthermore, by elegantly combining
image analyses of virus maturation in
target cell endosomes with studies
showing that administration of viral
protease inhibitors (which completely
prevent maturation even of endosomal
virus particles) blocks fusion and thus viral
entry, Chen and colleagues reveal that
viral morphogenesis and viral entry, once
thought of as consecutive events, can
actually be intertwined (as illustrated in
Figure 1, top). Such temporal overlap
may have evolved to allow HIV-1 to more
efficiently enter target cells, at least when
transmitted via the VS.
As it turns out, virus maturation is abso-
lutely required not only because it is
a prerequisite for uncoating (as cleavage
of the Gag polyprotein by the viral
protease is followed by a rearrangement
of its subunits, making the particles
unstable), but also because it allows the
viral envelope glycoprotein (Env) to
become fully fusogenic. Env mediates
fusion of viral and cellular membranes,
triggered by binding to the cellular
receptor and coreceptor. Interestingly,
however, Env is fully functional (i.e., fuso-
genic) only either before it associates
with theGag polyprotein in producer cells,
or after maturation—i.e., cleavage of Gag
(Murakami et al., 2004; Wyma et al.,
2004). Dale et al. (2011) suggest that virus
maturation within endosomes takes place
after a significant delay (hours). They
speculate that this may allow HIV-1 to
‘‘ride the endosomal train’’ for a while,
bringing its genome closer to the perinu-
clear region, which likely provides a more
favorable environment for the processes
that lead, ultimately, to the integration of
the viral genome into host chromosomes.
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Figure 1. Phase Overlap during HIV-1’s Replication Cycle
The early and late phase of the HIV-1 replication cycle are not separated by
discrete boundaries; instead, they overlap one another. The end of the early
phase (transcription of the viral genome) also represents the beginning of
the late phase (bottom of cycle). Dale et al. (2011) reveal that a similar overlap
takes place at the opposite pole of the replication cycle (upper half of figure):
maturation of HIV-1 particles, which demarcates the end of the late phase, can
take place in endosomes of target cells after initiation of the early phase of the
viral replication cycle.
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(2011) but cannot be com-
mented on here due to space
constraints is that such viral
maturation in endosomes
may protect the virus from
neutralizing antibodies that
recognize epitopes in Env
that are exposed only during
the fusion process.
Clearly, this study by
Chen and colleagues should
lead to further investigations
of the virus-cell fusion
process. It is currently unclear
exactly how Env, as part of
the viral particle, can bind
CD4, the HIV-1 entry
receptor, at the plasma
membrane, and then initiate
the fusion of viral and cellular
(endosomal) membranes
only upon viral maturation.
Also, due to the potential
significance of virus matura-
tion in endosomes of target
cells, we should expect that
this cellular compartment will
undergo scrutiny in further
studies. As pointed out previ-
ously by Bosch et al. (2008),
and as suggested also by
Dale et al. (2011), the pres-
ence or absence of certain
cellular markers (EEA1 andLAMP-1, respectively) indicates that these
endosomes appear to be of early rather
than late character. It will thus be of
interest to determine if distinct viral func-
tions prevent endosomal maturation
before HIV-1 can fuse with the cellular
membranes and thus escape into the
cytoplasm. Whether or not this will turn
out to be the case, the article by Chen
and colleagues demonstrates that the528 Cell Host & Microbe 10, December 15, 20relatively slow pace of virus maturation,
likely also causedby howGagand the viral
protease are spatially organized during
particle assembly, facilitates infection. In
that respect, this report adds to a series
of observations that describe how events
that are taking place still during the late
phase of the life cycle can be functionally
linked to viral entry, the event that kicks
off the early phase of viral replication.11 ª2011 Elsevier Inc.ACKNOWLEDGMENTS
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